RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Intuitive Ventures
I

Intuitive Ventures portfolio

Intuitive Ventures has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Website: intuitive.com.
Type: Corporate venture.
Portfolio on Recent Funding: 4.
Deals, last 12 months: 2.
Capital in their rounds: $329M.
Latest deal: Amber Therapeutics · Jul 24, 2026.
About this page

It is a corporate venture investor based in Sunnyvale, US, founded in 2020. Its most recent investment on record is Amber Therapeutics's $100M Series A round in July 2026, alongside Lightstone Ventures, NEA, 8VC and 2 others. By category, its portfolio leans toward Health and bio (4) and Manufacturing and industrial (1). It has co-invested with 8VC, NEA and F-Prime Capital, most often 8VC (2 rounds).

About Intuitive Ventures

Firm type: Corporate venture.
Headquarters: Sunnyvale, US.
Founded: 2020.
Stages: Seed, Series A.
Sectors: Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices.
Leads rounds: No.
Portfolio companies: 15.
Exits: 0.
Rounds led: 2.

What Intuitive Ventures invests in

Intuitive Ventures recent investments

CompanyRoundDateAlongside
AAmber TherapeuticsSeries A · $100MLightstone Ventures, NEA (lead), 8VC +2
CCellaresSeries B+Gates Frontier, Eclipse (lead), Willett Advisors LLC +6
SSovatoSeries B+ · $41MBeringea (lead), Laerdal Million Lives Fund, Polaris +3
EEndogenexSeries B+ · $88MLongitude Capital, Orlando Health Ventures, Mayo Clinic +3
AAmber TherapeuticsSeries A · $100MLightstone Ventures, NEA (lead), 8VC +2

How Intuitive Ventures invests

StageDealsCapital in rounds
Series B+ 3 60%$129M
Series A 2 40%$200M
YearDealsCapital in rounds
2024 2 40%$188M
2025 1 20%$41M
2026 2 40%$100M

Intuitive Ventures portfolio companies

CompanyRound with Intuitive VenturesTotal raisedLatest raise
AAmber Therapeutics
Health and bio
Series A · $100M$200MJul 24, 2026
Series A
CCellares
Health and bio
Series B+$357MJul 16, 2026
Series B+
SSovato
Health and bio
Series B+ · $41M$41MNov 4, 2025
Series B+
EEndogenex
Health and bio
Series B+ · $88M$138MMar 25, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 5 rounds on Recent Funding that name Intuitive Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Intuitive Ventures, which is a subset of its real portfolio. API: /api/v1/investors/intuitive-ventures (get a free API key). More: the most active VC firms and new venture capital funds.